130 related articles for article (PubMed ID: 32671628)
1. Phosphorylation of 5-LOX: The Potential Set-point of Inflammation.
He Z; Tao D; Xiong J; Lou F; Zhang J; Chen J; Dai W; Sun J; Wang Y
Neurochem Res; 2020 Oct; 45(10):2245-2257. PubMed ID: 32671628
[TBL] [Abstract][Full Text] [Related]
2. Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.
ul Ain Q; Greig NH; Nawaz MS; Rashid S; Kamal MA
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):197-202. PubMed ID: 24059322
[TBL] [Abstract][Full Text] [Related]
3. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
[TBL] [Abstract][Full Text] [Related]
4. 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach.
Sinha S; Doble M; Manju SL
Bioorg Med Chem; 2019 Sep; 27(17):3745-3759. PubMed ID: 31331653
[TBL] [Abstract][Full Text] [Related]
5. Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening.
Cerchia C; Küfner L; Werz O; Lavecchia A
Eur J Med Chem; 2024 Jan; 263():115932. PubMed ID: 37976708
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the enzymes in the leukotriene and prostaglandin pathways in inflammation by 3-aryl isocoumarins.
Ramanan M; Sinha S; Sudarshan K; Aidhen IS; Doble M
Eur J Med Chem; 2016 Nov; 124():428-434. PubMed ID: 27597418
[TBL] [Abstract][Full Text] [Related]
7. Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663.
Gilbert NC; Rui Z; Neau DB; Waight MT; Bartlett SG; Boeglin WE; Brash AR; Newcomer ME
FASEB J; 2012 Aug; 26(8):3222-9. PubMed ID: 22516296
[TBL] [Abstract][Full Text] [Related]
8. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
[TBL] [Abstract][Full Text] [Related]
9. Putative role of neuronal 5-lipoxygenase in an aging brain.
Manev H; Uz T; Sugaya K; Qu T
FASEB J; 2000 Jul; 14(10):1464-9. PubMed ID: 10877840
[TBL] [Abstract][Full Text] [Related]
10. Possible role for interactions between 5-lipoxygenase (5-LOX) and AMPA GluR1 receptors in depression and in antidepressant therapy.
Manev R; Mrazovac D; Manev H
Med Hypotheses; 2007; 69(5):1076-9. PubMed ID: 17449191
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-193b-3p alleviates focal cerebral ischemia and reperfusion-induced injury in rats by inhibiting 5-lipoxygenase expression.
Chen Z; Yang J; Zhong J; Luo Y; Du W; Hu C; Xia H; Li Y; Zhang J; Li M; Yang Y; Huang H; Peng Z; Tan X; Wang H
Exp Neurol; 2020 May; 327():113223. PubMed ID: 32032565
[TBL] [Abstract][Full Text] [Related]
12. Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells.
Li CT; Zhang WP; Lu YB; Fang SH; Yuan YM; Qi LL; Zhang LH; Huang XJ; Zhang L; Chen Z; Wei EQ
J Neurosci Res; 2009 Mar; 87(4):991-1001. PubMed ID: 18951527
[TBL] [Abstract][Full Text] [Related]
13. Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A
Joshi V; Venkatesha SH; Ramakrishnan C; Nanjaraj Urs AN; Hiremath V; Moudgil KD; Velmurugan D; Vishwanath BS
Pharmacol Res; 2016 Nov; 113(Pt A):265-275. PubMed ID: 27597642
[TBL] [Abstract][Full Text] [Related]
14. 'Mechanistic insights into 5-lipoxygenase inhibition by active principles derived from essential oils of Curcuma species: Molecular docking, ADMET analysis and molecular dynamic simulation study.
Gadnayak A; Dehury B; Nayak A; Jena S; Sahoo A; Panda PC; Ray A; Nayak S
PLoS One; 2022; 17(7):e0271956. PubMed ID: 35867724
[TBL] [Abstract][Full Text] [Related]
15. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease.
Rådmark O; Werz O; Steinhilber D; Samuelsson B
Biochim Biophys Acta; 2015 Apr; 1851(4):331-9. PubMed ID: 25152163
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
Masferrer JL; Zweifel BS; Hardy M; Anderson GD; Dufield D; Cortes-Burgos L; Pufahl RA; Graneto M
J Pharmacol Exp Ther; 2010 Jul; 334(1):294-301. PubMed ID: 20378715
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors.
Suh J; Yum EK; Cheon HG; Cho YS
Chem Biol Drug Des; 2012 Jul; 80(1):89-98. PubMed ID: 22404847
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
Muthuraman S; Sinha S; Vasavi CS; Waidha KM; Basu B; Munussami P; Balamurali MM; Doble M; Saravana Kumar R
Bioorg Med Chem; 2019 Feb; 27(4):604-619. PubMed ID: 30638966
[TBL] [Abstract][Full Text] [Related]
19. Development of 3,5-dinitrobenzoate-based 5-lipoxygenase inhibitors.
Shang E; Liu Y; Wu Y; Zhu W; He C; Lai L
Bioorg Med Chem; 2014 Apr; 22(8):2396-402. PubMed ID: 24685113
[TBL] [Abstract][Full Text] [Related]
20. The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma.
Oguh-Olayinka L; Agarwal V; Ranatunge D; Campbell A; Laufer S; Cawkwell L; Lind MJ
Pathol Oncol Res; 2020 Apr; 26(2):985-995. PubMed ID: 30941737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
